Skip to main content
Top
Published in: International Journal of Hematology 4/2021

01-04-2021 | Protein S Deficiency | Original Article

Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization

Authors: Masahiro Ieko, Taeko Hotta, Kumiko Watanabe, Tomoko Adachi, Sawako Takeuchi, Sumiyoshi Naito, Mika Yoshida, Kazumasa Ohmura, Nobuhiko Takahashi, Eriko Morishita, Hiroko Tsuda, Dongchon Kang

Published in: International Journal of Hematology | Issue 4/2021

Login to get access

Abstract

Patients with congenital protein S (PS) deficiency show a hereditary predisposition for thrombosis, and PS deficiency is prevalent among Japanese populations. Diagnosis is based on symptoms of thrombosis and reduced PS activity. Three reagents that use different measurement principles for determining PS activity are available in Japan. This study aimed to confirm the possibility of harmonization of these three reagents to establish a universal standard for PS activity in Japanese populations. Commercial normal plasma and plasma samples obtained from healthy individuals and healthy pregnant women were tested at three facilities using three reagents for measuring PS: STA-Staclot Protein S (STA-PS), HemosIL Protein S (Clotting) (IL-PS), and a total PS assay (SNT-PS). The within-run precision of each reagent was good, as each had a coefficient of variation of ≤ 3.8%. The dilution linearity for each reagent was also good. The correlation coefficient was 0.94 for STA-PS vs. IL-PS, 0.93 for SNT-PS vs. STA-PS, and 0.90 for SNT-PS vs. IL-PS, indicating a good correlation. Although the three reagents available in Japan for measuring PS activity use different measurement methods, each showed good performance, and large differences were not observed between the obtained values. Harmonization among them appears possible.
Literature
1.
go back to reference Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem. 2005;38:908–15.CrossRef Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem. 2005;38:908–15.CrossRef
2.
go back to reference Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217–23.CrossRef Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217–23.CrossRef
3.
go back to reference Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.CrossRef Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737–8.CrossRef
4.
go back to reference Ikejiri M, Wada H, Sakamoto Y, Ito N, Nishioka J, Nakatani K, et al. The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. Int J Hematol. 2010;92:302–5.CrossRef Ikejiri M, Wada H, Sakamoto Y, Ito N, Nishioka J, Nakatani K, et al. The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. Int J Hematol. 2010;92:302–5.CrossRef
5.
6.
go back to reference Faioni EM. Reliable estimates of plasma protein S levels: are we getting any closer? Thromb Haemost. 2001;86:1139–40.CrossRef Faioni EM. Reliable estimates of plasma protein S levels: are we getting any closer? Thromb Haemost. 2001;86:1139–40.CrossRef
7.
go back to reference Marlar RA, Gausman JN. Protein S abnormalities: a diagnostic nightmare. Am J Hematol. 2011;86:418–21.CrossRef Marlar RA, Gausman JN. Protein S abnormalities: a diagnostic nightmare. Am J Hematol. 2011;86:418–21.CrossRef
8.
go back to reference Adcock DM, Gosselin R, Kitchen S, Dwyre DM. The effect of dabigatran on select specialty coagulation assays. Am J Clin Pathol. 2013;139:102–9.CrossRef Adcock DM, Gosselin R, Kitchen S, Dwyre DM. The effect of dabigatran on select specialty coagulation assays. Am J Clin Pathol. 2013;139:102–9.CrossRef
9.
go back to reference Kuma H, Matsuda R, Nakashima A, Motoyama K, Takazaki S, Hatae H, et al. Protein S-specific activity assay system is not affected by direct oral anticoagulants. Thromb Res. 2018;168:60–2.CrossRef Kuma H, Matsuda R, Nakashima A, Motoyama K, Takazaki S, Hatae H, et al. Protein S-specific activity assay system is not affected by direct oral anticoagulants. Thromb Res. 2018;168:60–2.CrossRef
10.
go back to reference Brinkman HJ, Mertens K, van Mourik JA. Proteolytic cleavage of protein S during the hemostatic response. J Thromb Haemost. 2005;3:2712–20.CrossRef Brinkman HJ, Mertens K, van Mourik JA. Proteolytic cleavage of protein S during the hemostatic response. J Thromb Haemost. 2005;3:2712–20.CrossRef
11.
go back to reference Lu D, Xie RL, Rydzewski A, Long GL. The effect of N-linked glycosylation on molecular weight, thrombin cleavage, and functional activity of human protein S. Thromb Haemost. 1997;77:1156–63.CrossRef Lu D, Xie RL, Rydzewski A, Long GL. The effect of N-linked glycosylation on molecular weight, thrombin cleavage, and functional activity of human protein S. Thromb Haemost. 1997;77:1156–63.CrossRef
12.
go back to reference Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J. 1983;209:837–46.CrossRef Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J. 1983;209:837–46.CrossRef
13.
go back to reference Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C 4b-binding protein. J Biol Chem. 1986;261:12022–7.CrossRef Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C 4b-binding protein. J Biol Chem. 1986;261:12022–7.CrossRef
14.
go back to reference Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem. 1980; 255:5521–4. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem. 1980; 255:5521–4.
15.
go back to reference Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, et al. The roles of factor Va and protein S information of the activated protein C/protein S/factor Va inactivation complex. J Thromb Haemost. 2019;17:2056–68.CrossRef Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, et al. The roles of factor Va and protein S information of the activated protein C/protein S/factor Va inactivation complex. J Thromb Haemost. 2019;17:2056–68.CrossRef
16.
go back to reference Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A, et al. Down-regulation of PROS1 gene expression by 17β-estradiol via estrogen receptor α (ERα)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem. 2010;285:13444–53.CrossRef Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A, et al. Down-regulation of PROS1 gene expression by 17β-estradiol via estrogen receptor α (ERα)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem. 2010;285:13444–53.CrossRef
17.
go back to reference Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881–5.CrossRef Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881–5.CrossRef
18.
go back to reference Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol. 1988;68:437–43.CrossRef Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol. 1988;68:437–43.CrossRef
19.
go back to reference Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, et al. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost. 2000;84:15–21.CrossRef Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, et al. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost. 2000;84:15–21.CrossRef
20.
go back to reference Tsuda T, Jin X, Tsuda H, Ieko M, Morishita E, Adachi T, et al. New quantitative total protein S-assay system for diagnosing protein S type II deficiency: clinical application of the screening system for protein S type II deficiency. Blood Coagul Fibrinolysis. 2012;23:56–63.CrossRef Tsuda T, Jin X, Tsuda H, Ieko M, Morishita E, Adachi T, et al. New quantitative total protein S-assay system for diagnosing protein S type II deficiency: clinical application of the screening system for protein S type II deficiency. Blood Coagul Fibrinolysis. 2012;23:56–63.CrossRef
21.
go back to reference Noguchi K, Nakazono E, Tsuda T, Jin X, Sata S, Miya M, et al. Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent among young Japanese women. Blood Coagul Fibrinolysis. 2019;30:393–400.CrossRef Noguchi K, Nakazono E, Tsuda T, Jin X, Sata S, Miya M, et al. Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent among young Japanese women. Blood Coagul Fibrinolysis. 2019;30:393–400.CrossRef
Metadata
Title
Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization
Authors
Masahiro Ieko
Taeko Hotta
Kumiko Watanabe
Tomoko Adachi
Sawako Takeuchi
Sumiyoshi Naito
Mika Yoshida
Kazumasa Ohmura
Nobuhiko Takahashi
Eriko Morishita
Hiroko Tsuda
Dongchon Kang
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 4/2021
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-03049-8

Other articles of this Issue 4/2021

International Journal of Hematology 4/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine